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Ectonucleotide pyrophosphatase/phosphodiestrase 2 (Enpp2) 
isolated from the supernatant of human melanoma cells is a 
lysophospholipase D that transforms lysophosphatidylcholine 
into lysophospatidic acid. Although multiple analyses have 
investigated the function of Enpp2 in the hypothalamus, its 
role  in  the  uterus  during  the  estrous  cycle  is  not  well 
understood. In the present study, rat uterine Enpp2 was 
analyzed by RT-PCR, Western blotting, and immunohisto-
chemistry. Quantitative PCR analysis demonstrated that 
uterine Enpp2 mRNA was decreased during estrus compared 
to proestrus and diestrus. To determine whether uterine 
Enpp2  expression  is  affected  by  sex  steroid  hormones, 
immature  rats  were  treated  with  17β-estradiol  (E2), 
progesterone,  or  both  on  postnatal  days  14  to  16. 
Interestingly, the expression of Enpp2 mRNA and protein 
were down-regulated by E2 in the uterus during estrus but 
not during proestrus or diestrus, suggesting that Enpp2 may 
play  a  role  in  uterine  function  during  estrus.  Enpp2  is 
primarily localized in the stromal cells of the endometrium 
during proestrus and estrus. During diestrus, Enpp2 was 
highly expressed in the epithelial cells of the endometrium. 
Taken together, these results suggest that uterine Enpp2 
may be regulated by E2 and plays a role in reproductive 
functions during female rat development.
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Introduction
Ectonucleotide pyrophosphatase/phosphodiestrase 2 
(Enpp2), also known as autotaxin (ATX), is a 125-kDa 
secreted glycoprotein that is commonly detected in various 
biological fluids including in blood, synovial fluid, and 
cerebrospinal fluid. Enpp2 was originally isolated from the 
human melanoma cell line A2058 as an autocrine motility 
stimulation factor [8,12,27]. Enpp2 is thought to be a 
plasma enzyme because it is a member of the 
ectonucleotide pyrophosphatase and phosphodiesterase 
(NPP) family of ectoenzymes. NPP1 (PC-1) and NPP3 
(gp130RB
13-6, PD-Iβ, B10) share some characteristics with 
Enpp2, and are grouped together in the Enpp family 
[15,20,33]. However, only Enpp2 has lysophospholipase 
D (lysoPLD) activity, which has been observed in the 
microsomes of animals and produces the signaling 
molecule lysophosphatidic acid (LPA) from lysophos-
phatidylcholine (LPC) [36,39]. LPC is a major 
lysophospholipid and formed from phosphatidylcholine 
by phospholipase A2 [42]. It was recently reported that 
Enpp2 knock-out mice die on embryonic day 9.5 because 
Enpp2 plays a critical role in blood vessel formation in the 
yolk sac [35]. In addition, Enpp2 is able to activate cell 
motility through LPA production.
Enpp2 has a catalytic site that has been shown to regulate 
cell motility [22]. When a threonine residue (Thr210) in the 
catalytic site is replaced with an alanine, Enpp2 loses the 
ability to stimulate cell motility [14]. LPA produced by 
Enpp2 stimulates the motility of various types of cells 
[13,23,29]. Furthermore, this factor facilitates cell 
proliferation and migration during various biological 
processes including neurite retraction, platelet aggregation, 
smooth muscle contraction, actin stress formation, and 
cytokine and chemokine secretion by activating G 
protein-coupled receptors (GPCRs) to elicit multiple 
cellular responses [18,26,37].
LPA can be found in many biological fluids, including 
serum and follicular fluids [31], and acts through at least 
six GPCRs which are divided into two subgroups. One 
subgroup consists of receptors in the endothelial 
differentiation gene (EDG) family and the other includes 
receptors in the P2Y receptor family. LPA receptors 
(LPAR)1/EDG2, LPAR2/EDG4 and LPAR3/EDG7 
belong to the EDG family receptors, and LPAR4/GPCR23, 
LPAR5/GPCR92 and LPAR6/P2Y5 are members of the 
P2Y family receptors. Enpp2 can carry out multiple 380    Hyo-Jin Ahn et al.
functions through these LPARs [1,2,29,40]. In particular, 
LPAR3 has been shown to affect the female reproductive 
system. A previous study demonstrated that LPAR3- 
deficient mice had significantly reduced litter sizes and 
reduced rates of embryo implantation, indicating that 
LPAR3 can delay implantation and alter embryo spacing 
[41]. LPAR3 is therefore thought to play a critical role in 
the mammalian female reproductive system. Another 
recent report showed that mouse uterine LPAR3 mRNA 
expression was altered during early pregnancy and 
throughout the estrous cycle [41]. In addition, LPAR3 is 
regulated by progesterone and estrogen in the mouse 
uterus, and is regulated during early pregnancy at least in 
part by transcriptional regulation and subsequent LPAR3 
signaling [16].
The biological effects of estrogen (E2) and progesterone 
(P4) are mediated through estrogen receptors (ERs) and 
progesterone receptors (PRs), respectively, to regulate 
growth and differentiation in the human body [5,17]. ER 
has two different forms (ERα and ERβ) and is a member of 
the nuclear hormone family of intracellular receptor [7,24]. 
ER serves as ligand-activated transcription factor. PR also 
has two different forms (PR-A and PR-B) in humans which 
are members of an important superfamily of transcription 
regulatory factors [38].
Multiple analyses have identified numerous estrogen- 
responsive genes like Enpp2,  Igf2, and Igfbp2 in rat 
hippocampus [34]. However, little is known about the role 
of Enpp2 in the uterus during the estrous cycle and its 
regulation in this tissue is not well understood. 
Lysophosphatidic acid receptor 3 (LPAR3) is reportedly 
expressed in the uterus during the estrous cycle [41]. The 
expression and regulation of Enpp2, which catalyzes the 
synthesis of LPA, has not been studied in rats. Therefore, 
we examined the expression of Enpp2 in rat uterus during 
the estrous cycle. We also investigated the effects of the 
steroid hormones E2 and P4, along with receptor ER and 




E2 (17β-estradiol), P4 (progesterone), and mifepristone 
(RU486) were obtained from Sigma-Aldrich (USA). ICI 
182780 was purchased from Tocris (UK).
Animal treatment
Mature (14 weeks old) and immature (14 days old) female 
Sprague-Dawley rats were obtained from Koatech 
(Korea). All animals were housed in polycarbonate cages 
and acclimatized to an environmentally controlled room 
(temperature: 23 ± 2
oC, relative humidity: 50 ± 10%, 
frequent ventilation, and a 12-h light-dark cycle) before 
use. The mature rats were monitored for 14 days and daily 
vaginal smears were obtained and examined using a 
low-power light microscope. After this period of 
observation, the rats (n = 12) were separated according to 
estrous cycle stage: proestrus, estrus, and diestrus.
For hormone and antagonist treatments, immature female 
rats (n = 30) with matched body weight were divided into 
six groups (five rats each a group). The steroid hormones 
E2 (1.2 μg) or/and P4 (120 μg) were dissolved in 50 μL of 
10% ethanol (Sigma, USA) for an immature rat. And two 
steroid solutions were administered to the rats by 
subcutaneous injections. The animals were treated with E2 
(40 μg/kg BW), P4 (4 mg/kg BW), or E2 and P4 for 3 days, 
and were then euthanized 12 h after the final injection.
To determine the effects of E2, 10 immature rats were 
divided into two groups that were treated daily for 3 days 
with subcutaneous injections of the estrogen receptor 
antagonist ICI 182780 (10 mg/kg BW) 30 min prior to 
injection with either E2 (positive control, n = 5, 40 μg/kg 
BW) or ethanol (negative control, n = 5). To measure the 
effects of P4, 10 immature rats were divided into two 
groups that were treated daily for 3 days with subcutaneous 
injections of the progesterone antagonist RU486 (10 
mg/kg BW) 30 min prior to injection with either P4 
(positive control, n = 5, 4 mg/kg BW) or ethanol (negative 
control, n = 5). The Ethics Committee of Chungbuk 
National University (Korea) approved all experimental 
procedures involving animals.
Total RNA extraction and semi-quantitative PCR
The rats were euthanized under deep ether anesthesia, and 
uteri were rapidly excised and washed in cold, sterile 0.9% 
NaCl. Total RNA extraction from uteri with TRIzol 
reagent (Invitrogen, USA) is a common method of total 
RNA extraction according to the criteria of [10], and the 
concentration of RNA was set by pure, concentrated of 
RNA to an optical density of 1.0 at 260 nm using a Perkin 
Elmer (MBA2000; USA) Spectrophotometer. The 
concentration of stock solutions were then calculated and 
used for all subsequent dilutions. Total RNA (1 μg) was 
then reverse transcribed to first-strand complementary 
DNA (cDNA) using moloney murine leukemia virus 
reverse-transcriptase (iNtRON Bio, Korea) and random 
primers (9-mers; TaKaRa Bio, Japan). Enpp2 cDNA was 
amplified in a 20 μg PCR reaction containing 0.5 U Taq 
polymerase (iNtRON Bio, Korea), 1.5 mM MgCl2, 2 mM 
dNTP, and 100 pmol of the specific primers. The 
oligonucleotide primers used for producing Enpp2 cDNA 
were 5´-AGC TGC CTG GAC TTC ACT CA-3´ (sense) 
and 5´-GCA GGT ATG TCT TGA GGG TCA-3´ 
(antisense). PCR reactions were carried out with denaturation 
at 95
oC for 30 sec, annealing at 58
oC for 30 sec, and 
extension at 72
oC for 30 sec. The 1A gene was used as an 
internal control to normalize total cDNA; this is the Enpp2 is regulated by steroid hormones    381
cytochrome c oxidase subunit 1 which is a key enzyme for 
aerobic metabolism. The primers for 1A were 5´-CCA 
GGG TTT GGA ATT ATT TC-3´ (sense) and 5´-GAA 
GAT AAA CCC TAA GGC TC-3´ (antisense). Enpp2 and 
1A genes were quantified by performing 30 and 25 cycles, 
respectively. PCR products (8 μL) were separated on a 
2.3% agarose gel and photographed using a Gel Doc EQ 
(Bio-Rad, USA).
Western blot analysis
Uteri were rapidly excised and washed in cold, sterile 
0.9% NaCl. Soluble proteins were extracted using Pro- 
prep (iNtRON, Korea) according to the manufacturer’s 
instructions. Sixty μg of total protein per lane was 
separated by SDS-PAGE on a 7.5% gel and then 
transferred to polyvinylidene fluoride transfer membranes 
(Perkin Elmer, USA) with a TransBlot Cell (TE-22; 
Hoefer, USA) according to the manufacturer’s protocol. 
The blots were blocked in Tris-buffered saline with Tween 
20 (TBS-T) containing 5% skim milk for 2 h at room 
temperature and then incubated with primary antibodies 
against  Enpp2 (rabbit polyclonal, 1 : 500; Cayman 
Chemicals, USA) or beta-actin (mouse monoclonal, 1 : 
4,000; Santa Cruz Biotech, USA). After washing in TBS-T 
(Tris-buffered saline with containing 5% Tween20) buffer, 
the membranes were incubated with appropriate 
horseradish peroxidase-conjugated secondary antibodies 
(anti-rabbit, 1 : 2,500, Santa Cruz Biotech, USA; or 
anti-mouse, 1 : 5,000, Santa Cruz Biotech, USA) for 2 h at 
room temperature. After washing using the 10 mL of 
TBS-T, antibody binding was visualized by incubating the 
blots in enhanced chemiluminescence chemiluminescence 
reagent (Amersham Biosciences, UK) and subsequent 
exposure to Biomax Light film (Kodak, USA) for periods 
ranging from 1 to 5 min. Signal specificity was confirmed 
by incubating the blots without either primary antibody. 
All bands were normalized to the β-actin immunoreactive 
bands on the same membrane after stripping (stripping 
solution is composed with SDS (10 g) and Tris (3.785 g). 
The density of each band was measured with ImageJ 
software (NIH, USA). Density measurements for each 
band were performed with NIH ImageJ software. 
Background samples from an area near each lane were 
subtracted from each band to obtain mean band density. 
Data were analyzed for significant differences by one-way 
ANOVA (Prism 4 Graph Pad; Graph Pad Software, USA).
Immunohistochemical staining
The localization of Enpp2 protein was determined using 
immunohistochemistry. Uteri were embedded in paraffin 
and then sectioned. Sections (5-μm thick) were then 
deparaffinized in xylene and hydrated in decreasing 
concentrations of ethanol. Endogenous peroxidase activity 
was blocked with 3% hydrogen peroxide in TBS-T for 30 
min. Nonspecific reactions were blocked by incubating the 
sections in 10% normal goat serum (Vector, USA) for 2 h 
at room temperature. The sections were subsequently 
incubated overnight at 4
oC with a polyclonal rabbit 
antibody (1 : 500, Cayman Chemicals, USA) against 
Enpp2 dissolved in 10% normal goat serum. After washing 
with TBS-T, the sections were incubated with biotinylated 
secondary antibody (anti-rabbit IgG, 1 : 1,000; Vector 
Laboratories, USA) for 1 h at 37
oC and further incubated 
with ABC-Elite (Vector, USA) for 30 min at 37
oC. 
Diaminobenzidine (Sigma, USA) was used as a 
chromogen, and the sections were counterstained with 
hematoxylin before being mounted in mounting solution 
(Cytoseal-60; Richard Allen Scientific Kalamazoo, USA).
Statistical analysis
Data were analyzed using a nonparametric one-way 
ANOVA using Tukey’s test followed by Dunnett’s test for 
multiple comparisons to the negative controls. Data were 
ranked according to these tests. All statistical analyses 
were performed using SPSS for Windows (SPSS, USA). 
p-values < 0.05 were considered statistically significant.
Results
Patterns  of  uterine  Enpp2  mRNA  and  protein 
expression throughout the estrous cycle
To investigate expression of Enpp2 in rat uterus during 
the estrous cycle, rat uteri from each stage of the estrous 
cycle were classified according to vaginal cell 
morphology. Total RNA was extracted and RT-PCR was 
carried out using specific primers. The level of Enpp2 
mRNA was significantly increased during diestrus 
compared to other stages of the cycle and was decreased 
during estrus (Fig. 1). Western blot analysis was performed 
to measure Enpp2 protein expression in rat endometrium 
throughout the estrous cycle. Enpp2 protein was highly 
expressed during diestrus, but the expression was reduced 
during proestrus and estrus (Fig. 2). These results indicate 
that the expression of uterine Enpp2 mRNA and protein are 
tightly regulated throughout the estrous cycle and may be 
influenced by steroid hormone fluctuations during this 
cycle.
Effects of the sex steroid hormones E2 and P4 on 
Enpp2
To investigate the effects of E2 and P4 on Enpp2 
expression, immature rats were injected daily with E2 
and/or P4 for 3 days. Uterine expression of Enpp2 mRNA 
and protein was significantly decreased by E2 compared to 
the vehicle (Figs. 3 and 4). To investigate the ER-mediated 
effects of E2 on uterine Enpp2 transcription, ICI 182780, 
an ER antagonist, was injected into immature rats 30 min 
prior to E2 treatment. Pretreatment with the ER antagonist 382    Hyo-Jin Ahn et al.
Fig. 1. Uterine ectonucleotide pyrophosphatase/phosphodiestrase
2 (Enpp2) mRNA expression in mature female rats throughout 
the estrous cycle. There was a significant difference in Enpp2
expression levels during diestrus compared to the other stages 
(**p < 0.01, ***p < 0.001).
Fig. 2. Uterine Enpp2 expression in mature female rats during the
estrous cycle. There was a significant difference in Enpp2 
expression during diestrus compared to proestrus and estrus (*p
< 0.05, **p < 0.01).
Fig. 3. Effects of steroid hormones along with estrogen receptor
and progesterone receptor antagonists on uterine Enpp2 mRNA 
expression. Expression of Enpp2 was analyzed by RT-PCR (**p
< 0.01, ***p < 0.001). E2: 17β-estradiol, P4: progesterone, ICI:
ICI 182780, RU: RU 486.
Fig. 4. Effects of steroid hormones and ER/PR antagonists on 
uterine Enpp2 protein expression. The expression of Enpp2 
protein was analyzed by Western blotting (**p < 0.01, ***p < 
0.001).
completely reversed the E2-induced reduction of Enpp2 
mRNA and protein expression (Figs. 3 and 4). This finding 
suggests that ERs are involved in E2-mediated regulation 
of Enpp2 expression in the uterus.
Localization of Enpp2 in rat uterus
To examine the localized expression of Enpp2 protein in 
the uterus, we performed immunohistochemistry using an 
anti-Enpp2 antibody on tissue sections obtained during 
different stages of the estrous cycle (proestrus, estrus, and 
diestrus). Enpp2 protein was found in stromal cells during Enpp2 is regulated by steroid hormones    383
Fig. 5. Localization of Enpp2 expression in the rat uterus. 
Proestrus (A), estrus (B), and diestrus (C) by immuno-
histochemistry. Arrows indicate the positive cells. ×400.
the proestrus and estrous stages. Enpp2 protein expression 
was also observed in endometrial luminal epithelial cells 
and the endometrial glands during diestrus (Fig. 5).
Discussion
Enpp2 has lysophospholipase D activity which enables it 
to catalyze the hydrolysis of LPC phosphodiester bonds 
and allow lysoPLD to generate the signaling molecule LPA 
from LPC [21,28,36]. Enpp2 has also been shown to act 
through LPAR. A recent report described uterine 
expression of LPAR3 during the estrous cycle, but the 
expression and regulation of Enpp2, an enzyme that has a 
major role in LPA production, has not been studied in rats 
[41]. Previous studies have also confirmed that the 
expression of LPAR3 mouse uterine is altered by estrogen 
and progesterone [16,19,41]. In addition, expression of 
LPAR3 plays a critical role in embryo implantation and 
early pregnancy [25]. Enpp2 plays a major role in LPA 
synthesis, and so we hypothesized that Enpp2 is also 
affected by sex hormones during the estrous cycle. In our 
study, we observed the highest expression of Enpp2 
mRNA at diestrus stage. During diestrus stage, E2 and P4 
levels are at the lowest of the during estrus cycle [11,32]. 
These results indicate that the level of Enpp2 expression 
was may be involved with sex steroids (E2, P4) of the rat 
during estrus cycle.
To determine the effects of these hormones on uterine 
Enpp2 transcription, immature rats were injected daily 
with E2 and/or P4. E2-treated rats showed lower uterine 
expression of Enpp2 mRNA and protein. These results 
imply that E2 may be an inhibitory regulator of uterine 
Enpp2 transcription in rats. Although these findings 
suggest that expression of the Enpp2 gene is reduced in 
response to estrogen in rat uterus, the relation between 
Enpp2 and steroid hormone metabolism is unknown. In 
this study, we observed ER and PR-mediated Enpp2 
expression following ER and PR antagonist treatment. 
However, we need to elucidate the detailed mechanism(s) 
of ER and PR-mediated Enpp2 expression in further 
studies.
A published report showed that the expression of Enpp2 is 
estrogen-responsive and that its expression is cell type- 
specific [34]. A recent study examined the expression of 
ovine uterine Enpp2 throughout the estrous cycle and 
during pregnancy [25]. However, it was found that Enpp2 
mRNA levels are not significantly different on days 12 to 
15 of pregnancy compared with those of non-pregnant 
females [25]. We postulate that the expression of Enpp2 
varies according to cell type in the reproductive system as 
a result of this hormonal regulation.
Enpp2 (ATX) is a known factor that stimulates tumor cell 
motility. We believe that Enpp2 also plays a role in 
regulating the proliferation of uterine cells. Using 
immunohistochemistry, we analyzed the localization of 
Enpp2 protein during the estrous cycle and the effects of 
sex steroid hormones on Enpp2 expression. Enpp2 
expression varied throughout the estrous cycle. The result, 
during the proestrus and estrus stages, Enpp2 was detected 
primarily in stromal cells. However, this protein was 
detected in luminal epithelial cells during diestrus.
Most previous studies of this protein have focused on its 
ability to regulate the proliferation of uterine myoma cells 
[6]. LPA has been shown to stimulate stress fiber formation 
and to have a mitogenic effect on the human myometrium 
[6]. It was recently reported that uterine leiomyoma cell 
proliferation is regulated by phospholipase D and Enpp2 
[6]. According to previously reported that LPA induces the 
expression of IL-8 through LPAR1 [40]. LPAR1 is 
expressed during the proliferative and secretory phases in 
human endometrial stromal cells. LPA is a critical 
mediator of the MAPK/p38 and NF-κB signaling 
pathways [9]. Thus, we postulate that LPA also mediates 
reproductive function because Enpp2 plays a critical role 
in the reproductive system by producing LPA. LPA can be 
found in epithelial cells, stromal cells, and blood vessels 
[31]. Thus, we believe that LPA may act as an autocrine 
and paracrine mediator of epithelial cell-to-epithelial cell 
and epithelial cell-to-stromal cell communication [31].
The endometrium undergoes structural modification and 
changes during the estrous cycle in rodents [4]. E2 and P4 
can also mediate changes in the structure and function of 
the uterus and control the estrous cycle [3,30]. Endometrial 
proliferation occurs during the proestrous and estrous 
stage, and is degenerated during diestrus by steroid 
hormones. In this study, we observed that migration of 
ENPP2-induced stromal cells from basolateral side to the 384    Hyo-Jin Ahn et al.
cytoplasm of endometrium during proestrus, estrus and 
diestrus cycle. It can be assumed that Enpp2 expression 
may be involved in endometrial cell proliferation and 
migrate from the basolateral side to endometrial layer in 
the stromal cells of rat uterus.
Although we were not able to confirm the precise 
localization of LPA expression, we believe that it may be 
similar to that of Enpp2 because LPA is synthesized by 
Enpp2. We do not know why Enpp2 expression is inhibited 
by estrogen, but the results from other studies indicate that 
Enpp2 expression differs according to cell type and species 
[34].
In summary, we examined the expression of Enpp2 
mRNA and protein in rat uterus, and showed for the first 
time that this expression fluctuates during the estrous 
cycle. In addition, the uterine expression of Enpp2 mRNA 
and protein appears to be regulated by E2, suggesting that 
uterine Enpp2 may play an important role in the female rat 
reproductive system. As referred to earlier, new research 
will be required to obtain further insights into the detailed 
mechanism(s) of ER and PR-mediated Enpp2 expression. 
We were expected to interesting results that LPA and 
Enpp2 should be studied together in this model.
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